Literature DB >> 25233445

Serum differential proteomic analysis of endometriosis and adenomyosis by iTRAQ technique.

Long Xiaoyu1, Zhang Weiyuan2, Jiang Ping3, Wan Anxia3, Zhou Liane3.   

Abstract

OBJECTIVE(S): Adenomyosis and endometriosis are two different diseases, although they have similar pathogenesis and characteristic. The serum differential expressed proteins in adenomyosis and endometriosis may result from the different pathogenesis of two diseases. Proteomic technology is a useful method for detecting all the proteins in samples. We try to use isobaric tags for relative and absolute quantitation (iTRAQ) technology to explore the association between the potential pathogenesis of these two diseases and these identified proteins. STUDY
DESIGN: The serum samples from 20 patients with adenomyosis and from 20 patients with endometriosis were analyzed using iTRAQ technology to detect the differential expression of proteins. The validation of the proteins was performed using Western blot.
RESULTS: In the serum of women with adenomyosis and with endometriosis, 14 proteins were found differentially expressed using iTRAQ technology. Nine proteins were high-expression in adenomyosis group and four proteins increased in endometriosis group. And the differential expression proteins were validated by Western blot. CONCLUSION(S): The proteins increased in adenomyosis group are related to blood coagulation and complement activation effects, and the proteins high-expression in endometriosis mainly take part in the process of inflammatory response and regulation of apoptosis. The differentially expressed proteins in two groups may due to the different pathogenesis of two diseases.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adenomyosis; Endometriosis; iTRAQ technology

Mesh:

Substances:

Year:  2014        PMID: 25233445     DOI: 10.1016/j.ejogrb.2014.08.034

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis.

Authors:  Christopher N Herndon; Lusine Aghajanova; Shaina Balayan; David Erikson; Fatima Barragan; Gabriel Goldfien; Kim Chi Vo; Shannon Hawkins; Linda C Giudice
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

Review 2.  Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development.

Authors:  Hiroshi Kobayashi
Journal:  Reprod Sci       Date:  2022-07-15       Impact factor: 2.924

3.  Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis.

Authors:  Qiao Lin; Tiantian Li; ShaoJie Ding; Qin Yu; Xinmei Zhang
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

4.  ITRAQ-based proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells of adenomyosis.

Authors:  Yong Luo; Zeng-Ming Li; Li-Ping Li; Yang Zou; Xiao-Yun Xu; Zi-Yu Zhang; Fa-Ying Liu; Yan Xiong; Lei Wan
Journal:  Arch Gynecol Obstet       Date:  2021-01-20       Impact factor: 2.344

5.  Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas.

Authors:  Charoula Matalliotaki; Michail Matalliotakis; Maria I Zervou; Athina Patelarou; Ioannis Koliarakis; Demetrios A Spandidos; Aydin Arici; Ioannis Matalliotakis; George N Goulielmos
Journal:  Exp Ther Med       Date:  2019-12-05       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.